Polymorphic and amorphous salt forms of squalamine dilactate
US8716270B2 · kind B2 · utility
0Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 23, 2011 |
| Grant date | May 6, 2014 |
| Priority date | — |
| Expiry date | Sep 3, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J41/0005
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to select squalamine salts, methods of their synthesis, their therapeutic use and their advantages relating to manufacturing, product stability and toxicity. More specifically, this application is directed to various forms of the dilactate salt of squalamine and their utility in inhibiting neovascularization and endothelial cell proliferation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.